A single-cell transcriptional study performed in PBMCs of COVID-19 patients further suggests the involvement of IFNα and IFNγ in promoting severe disease via activation of STAT1/IRF3 in CD4+ and CD8+ T cells, naive T cells, and DCs [27]. The gene discussed is IFNG; the disease is COVID-19.